Skip to content

Ceftolozane

Cephalosporin Antibacterial — ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: ceftolozane sulfate, CXA-101, FR 264205, FR-264205, FR264205, zerbaxa

OnpEMA approvedFDA approvedPMDA approvedATC J01DI54

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ceftolozane is an onp drug in the Cephalosporin Antibacterial class catalogued in DrugCentral. It was first approved by the FDA in 2014. Recorded indications include Abdominal abscess, Abscess of liver, Acute pyelonephritis and Bacterial cystitis.

  • Approval status: onp (first approved 2014 by the FDA).
  • Drug class: Cephalosporin Antibacterial.
  • Indications: Abdominal abscess, Abscess of liver, Acute pyelonephritis, Bacterial cystitis and Bacterial peritonitis and others.
  • ATC code: J01DI54 (Other cephalosporins and penems).
  • Molecular formula: C23H31N12O8S2+; molecular weight 667.71 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (14)

  • Abdominal abscess
  • Abscess of liver
  • Acute pyelonephritis
  • Bacterial cystitis
  • Bacterial peritonitis
  • Bacterial pyelonephritis
  • Cholecystitis
  • Haemophilus influenzae pneumonia
  • Infectious disease of abdomen
  • Nosocomial pneumonia
  • Sepsis caused by Haemophilus influenzae
  • Sepsis caused by Serratia
  • Urinary tract infectious disease
  • Ventilator-acquired pneumonia

Mechanism & targets

Established pharmacologic classCephalosporin Antibacterial

Regulatory approvals (3)

DateAgencyMarketed asApplicantOrphan
2019-01-08PMDA—MSD K.K.
2015-09-18EMA—MERCK SHARP & DOHME B.V.
2014-12-19FDA—CUBIST PHARMS

ATC classification

ATC codeTherapeutic hierarchy
J01DI54ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER BETA-LACTAM ANTIBACTERIALS › Other cephalosporins and penems

Chemical structure

Molecular formulaC23H31N12O8S2+
Molecular weight667.71 g/mol
CAS number—
InChIKeyJHFNIHVVXRKLEF-DCZLAGFPSA-O
PubChem CID53234134
CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ceftolozane used for?

DrugCentral lists the following indications for Ceftolozane: Abdominal abscess, Abscess of liver, Acute pyelonephritis, Bacterial cystitis, Bacterial peritonitis, Bacterial pyelonephritis, Cholecystitis and Haemophilus influenzae pneumonia and others.

When was Ceftolozane first approved?

Ceftolozane was first approved by the FDA in 2014.

What drug class does Ceftolozane belong to?

Ceftolozane is in the Cephalosporin Antibacterial class.

What is the chemical formula of Ceftolozane?

Ceftolozane has the molecular formula C23H31N12O8S2+ and a molecular weight of 667.71 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusONP
First approval2014-12-19
AgencyFDA
Targets0
Indications14
FormulaC23H31N12O8S2+
DrugCentral ID4922
Interactive profile